All hands were on deck for the launch of Stelo, produced by its parent company Dexcom. With public anticipation of this OTC biosenor backed by an actual diabetes-product company, Stelo had big shoes to fill. Before launch, I was tasked with helping write the initial messaging framework that would later become the basis for all creative work moving forward. Stelo later gained partnerships, making way for more messaging opportunities. To differentiate this product from sensors made by the same company, there was a sharp shift in tone of voice and overall style. While our team was busy helping create assets for Stelo, I proved that my ability to switch voice was not all talk.

My role remains as one of the lead writers for consumer Stelo work.